Publication - Progress report

New Medicines Reviews 2013

Published: 3 May 2013
Part of:
Health and social care
ISBN:
9781782565604

Reports on the role of SMC & Review of IPTR & ADTC

91 page PDF

324.6 kB

91 page PDF

324.6 kB

Contents
New Medicines Reviews 2013
Appendix 1: Medicines approved by SMC April-September 2012

91 page PDF

324.6 kB

Appendix 1: Medicines approved by SMC April-September 2012

Drug Name Publication date SMC ID Manufacturer Status
Everolimus (Afinitor) 06/04/2012 777/12 Novartis Pharmaceuticals UK Ltd Accepted
Insulin detemir (Levemir) 06/04/2012 780/12 Novo Nordisk Restricted
Etanercept (Enbrel) 06/04/2012 781/12 Wyeth Pharmaceuticals Restricted
Etanercept (Enbrel) 06/04/2012 782/12 Wyeth Pharmaceuticals Restricted
Collagenase (Xiapex) 16/04/2012 715/11 Pifzer Restricted
Pregablin oral solution (Lyrica) 04/05/2012 765/12 Pfizer Restricted
Alteplase (Actilyse) 04/05/2012 714/11 Boehringer Ingelheim Ltd Accepted
Tobramycin inhalation powder 28mg (TOBI Podhaler) 04/05/2012 783/12 Novartis Pharmaceuticals Accepted
Dexmedetomidine hydrochloride (Dexdor) 04/05/2012 784/12 Orion Pharma Accepted
Exenatide twice-daily in combinaton with insulin (Byetta) 04/05/2012 785/12 Lilly UK Accepted
Dexamethasone (Ozurdex) 0.7 mg injecton 04/05/2012 652/10 Allergan Restricted
Fidaxomicin (Dificlir) 08/06/2012 791/12 Astellas Pharma Ltd Restricted
Eplerenone (Inspra) 08/06/2012 793/12 Pfizer UK Accepted
Tadalafil (Adcirca) 08/06/2012 710/11 Eli Lilly & Co. Ltd Restricted
Golimumab (simponi) 08/06/2012 674/11 MSD/Schering Plough Restricted
Pegylated interferon alfa 2b (Viraferon Peg) 08/06/2012 794/12 Merck Sharp & Dohme Ltd Accepted
Rufinamide 40mg/mL oral suspension (Inovelon®) 08/06/2012 795/12 Eisai Ltd Restricted
Abiraterone (Zytiga) 06/07/2012 764/12 Janssen-Cilag Ltd Restricted
Mercaptopurine (Xaluprine) 06/07/2012 798/12 Nova Laboratories Limited Accepted
Fingolimod (Gilenya) 10/08/2012 763/12 Novartis Pharmaceuticals UK Ltd Restricted
Tocilizumab (RoActemra) 10/08/2012 774/12 Roche Restricted
Colecalciferol (Fultium-D3) 10/08/2012 801/12 Internis Pharmaceuticals Ltd Accepted
Tegafur/gimeracil/oteracil (Teysuno) 10/08/2012 802/12 Nordic Pharma Ltd Restricted

Contact

Email: VERONICA MOFFAT